SCD1 enzyme linked to cancer treatment resistance
Medical Xpress1 min read51 words
The Cancer Metabolism and Tumor Microenvironment Laboratory at the University of Liège has uncovered a previously unrecognized mechanism that promotes cancer cell survival under therapeutic pressure. Published in MedComm, the study shows how a key enzyme in lipid metabolism, stearoyl-CoA desaturase-1 (SCD1), cooperates with an epigenetic regulator to support tumor growth.
🤖 AI-generated content — This article was automatically summarised from public RSS feeds by AutoBrief. Verify important information with the original source.